Rossari Biotech to consider financial results, dividend on April 25

Rossari Biotech Limited (BSE: ROSSARI) announced that a meeting of its Board of Directors is scheduled for April 25, 2025, to review and approve the audited financial statements and financial results for the quarter and financial year ending March 31, 2025. The board will also consider recommending a final dividend, if any, for the financial year ended March 31, 2025. The company had previously announced a trading window closure for designated persons and their immediate relatives, effective from April 1, 2025, until 48 hours after the financial results are made public. Further information will be available on the company's website at www.rossari.com.